, increasing number of invasive diagnostic, and treatment methods. However, the
drugs traditionally used
Мироненкова, Ж.В.,
Муссави, М.Э.,
Давлетьянова, А.Ф.,
Mironenkova, Zh.V.,
Moussawi, M.A.,
Davletianova, A.F. (2017) with antiretroviral
medicines is given. The holders of marketing authorization
of these
drugs in Russia are indicated
Chatelain, Pierre,
Malievskiy, Oleg,
Radziuk, Klaudziya,
Senatorova, Ganna,
Abdou, Magdy O.,
Vlachopapadopoulou, Elpis,
Skorodok, Yulia,
Peterkova, Valentina,
Leff, Jonathan A.,
Beckert, Michael (2017) unrelated to the study
drug. Injection site tolerance was good. One TransCon GH subject developed a low